Charles River Laboratories International Shares Rise Following Trading Report
November 4, 2023
☀️Trending News
Charles River Laboratories ($NYSE:CRL) International, Inc. (CRL) experienced a rise of share prices following the release of a trading report. Analyzing the trading report, investors noted an increase in the company’s stock value due to its strong financial results and ongoing commitment to provide clients with high-quality services. CRL is a global leader in outsourced services for drug development and research, offering pre-clinical and clinical services as well as laboratory research models.
Its commitment to scientific excellence and operational efficiency have enabled it to continue to be a preferred partner for customers around the world. With the stock market seeing an upswing in CRL’s shares, this can be seen as a positive sign for the company’s future prospects.
Price History
Charles River Laboratories International (CRL) experienced a positive trend in their stock prices on Friday, January 8th. The stock opened at $178.8 and closed at $181.9, a 4.1% increase from the previous closing price of 174.7. This rise in CRL’s stock reflects the overall positive sentiment in the market, as well as a strong trading report from the company. Investors are hopeful that the stock will continue to increase in value as the company continues to produce positive returns. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for CRL. More…
| Total Revenues | Net Income | Net Margin |
| 4.18k | 484.03 | 11.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for CRL. More…
| Operations | Investing | Financing |
| 625.04 | -293.03 | -346.77 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for CRL. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.77k | 4.47k | 63.42 |
Key Ratios Snapshot
Some of the financial key ratios for CRL are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 15.0% | 20.2% | 17.8% |
| FCF Margin | ROE | ROA |
| 6.9% | 14.6% | 6.0% |
Analysis
Having completed a thorough analysis of the wellbeing of CHARLES RIVER LABORATORIES INTERNATIONAL, GoodWhale has classified it as a “gorilla” company. This type of company is defined as having achieved stable and high revenue or earning growth due to its strong competitive advantage. For investors, this type of company is likely to be of interest as it is strong in terms of growth and profitability and weak in terms of assets and dividends. With a high health score of 8/10 in terms of cashflows and debt, CHARLES RIVER LABORATORIES INTERNATIONAL is capable to safely ride out any crisis without the risk of bankruptcy. This makes it an attractive investment opportunity for those looking for a reliable return on their investments. More…
Peers
The global market for contract research services is growing rapidly as more and more companies are outsourcing their research and development needs. This growth is being driven by the increasing costs of R&D, the need for faster timelines, and the desire to tap into the expertise of experienced professionals. As the market expands, so does the competition, and Charles River Laboratories International Inc is up against some stiff competition from the likes of Microba Life Sciences Ltd, IDenta Corp, and Eurofins Scientific SE.
– Microba Life Sciences Ltd ($ASX:MAP)
Denta Corp is a publicly traded company that provides dental products and services. The company has a market capitalization of 1.5 million as of 2022 and a return on equity of -10.42%. The company’s products and services include dental implants, dentures, and other dental prosthetics. Denta Corp also provides dental education and training services. The company was founded in 2006 and is headquartered in New York, New York.
– IDenta Corp ($OTCPK:IDTA)
Eurofins Scientific SE is a global leader in the provision of analytical testing and scientific services. The company has a market capitalization of 13.54 billion as of 2022 and a return on equity of 12.32%. The company provides a range of services including food testing, environmental testing, pharmaceutical testing, and forensics. Eurofins Scientific SE has a network of over 800 laboratories across 47 countries.
Summary
Charles River Laboratories International Inc. (CRL) is a leading provider of products and services used in the drug discovery, development, and safety testing process. CRL has had a strong history of providing investors with positive returns year over year. With a strong balance sheet and an increasing backlog of orders, investors remain confident in CRL’s long-term growth prospects.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
